Core Viewpoint - Altria is expected to report quarterly earnings of $1.31 per share, a 1.6% increase year-over-year, with revenues projected at $5 billion, reflecting a 2% decrease compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised downward by 0.4% over the past 30 days, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts estimate that revenues net of excise taxes for Oral Tobacco Products will reach $673.99 million, representing a year-over-year increase of 1.7% [5]. - For Smokeable Products, revenues net of excise taxes are expected to be $4.29 billion, indicating a year-over-year decrease of 3% [5]. Operating Income Estimates - Reported Operating Companies Income for Oral Tobacco Products is projected at $466.35 million, up from $453.00 million a year ago [6]. - Adjusted Operating Companies Income for Smokeable Products is expected to be $2.67 billion, down from $2.71 billion in the same quarter last year [6]. Stock Performance - Over the past month, Altria's shares have increased by 7.5%, compared to a 0.2% change in the Zacks S&P 500 composite [6]. - Altria currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [6].
Insights Into Altria (MO) Q4: Wall Street Projections for Key Metrics